Athletes recovering from COVID-19 with no long-term heart damage | Comorbid conditions & TAVR outcomes

“Our results show that none of the athletes who underwent cardiac MRI had abnormal findings," one researcher explained. 

In a recent advisory, the FDA specifically mentioned Abbott's HeartMate 3 LVAD as an effective alternative to Medtronic's HVAD system. 

Hypertension, for instance, can increase an individual's risk of post-TAVR hospitalization or mortality, according to a new analysis of more than 350 high-risk patients.  

This new analysis helps paint a better picture of how COVID-19 has affected patient care in the United States.

The device's internal pump was associated with a heightened risk of adverse outcomes, including stroke and death. 

AFib patients undergoing cardiac surgery may benefit from concomitant LAAO, according to a new study in the New England Journal of Medicine.

Virtual care, remote patient monitoring and AI-based research are three specific topics the groups are expected to discuss.

Major league pitchers put a tremendous amount of stress on their arms and new imaging insights can give players a competitive advantage on their road to recovery.